These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
157 related items for PubMed ID: 17964968
1. Complete remission of nephrotic syndrome of hepatitis B virus-associated membranous glomerulopathy after lamivudine monotherapy. Chuang TW, Hung CH, Huang SC, Lee CM. J Formos Med Assoc; 2007 Oct; 106(10):869-73. PubMed ID: 17964968 [Abstract] [Full Text] [Related]
2. Successful treatment of hepatitis B virus-associated membranous nephropathy with lamivudine. Okuse C, Yotsuyanagi H, Yamada N, Ikeda H, Takahashi H, Suzuki M, Kondo S, Kimura K, Koike J, Itoh F. Clin Nephrol; 2006 Jan; 65(1):53-6. PubMed ID: 16429843 [Abstract] [Full Text] [Related]
3. [Treatment of hepatitis B virus-associated membranous glomerulonephritis with interferon alfa in a 7 year old boy]. Steiss JO, Piske-Keyser K, Gröne HJ, Gortner L. Klin Padiatr; 2000 Jan; 212(5):283-6. PubMed ID: 11048290 [Abstract] [Full Text] [Related]
4. Successful treatment of occult hepatitis B virus infection related membranous nephropathy after entecavir therapy. Xiong QF, Zhong YD, Hu ZL, Yang YF. Acta Clin Belg; 2015 Jun; 70(3):223-5. PubMed ID: 25510219 [Abstract] [Full Text] [Related]
5. Complete remission of hepatitis B virus-related membranous nephropathy after entecavir monotherapy. Yang YF, Xiong QF, Zhao W, Zhong YD. Clin Res Hepatol Gastroenterol; 2012 Oct; 36(5):e89-92. PubMed ID: 22572521 [Abstract] [Full Text] [Related]
6. Lamivudine for the treatment of membranous glomerulopathy secondary to chronic Hepatitis B infection. Gan SI, Devlin SM, Scott-Douglas NW, Burak KW. Can J Gastroenterol; 2005 Oct; 19(10):625-9. PubMed ID: 16247526 [Abstract] [Full Text] [Related]
7. Lamivudine for nephrotic syndrome related to hepatitis B virus (HBV) infection. Kanaan N, Horsmans Y, Goffin E. Clin Nephrol; 2006 Mar; 65(3):208-10. PubMed ID: 16550752 [Abstract] [Full Text] [Related]
8. Hepatitis B virus related membranous glomerulonephritis and proteinuria treated with lamivudine and tenofovir. Das P, Vivek V, Ford M, Kingdon E, Holt S. BMJ Case Rep; 2011 Aug 31; 2011():. PubMed ID: 22679045 [Abstract] [Full Text] [Related]
9. Successful treatment of hepatitis B virus associated nephrotic syndrome with oral Lamivudine in a Nigerian child: a case report. Ladapo TA, Onifade EU, Lesi AE, Lesi OA. J Trop Pediatr; 2012 Apr 31; 58(2):157-8. PubMed ID: 21624925 [Abstract] [Full Text] [Related]
10. Remission of nephrotic syndrome of HBV-associated membranous glomerulopathy following treatment with interferon. Shapiro RJ, Steinbrecher UP, Magil A. Am J Nephrol; 1995 Apr 31; 15(4):343-7. PubMed ID: 7573195 [Abstract] [Full Text] [Related]
12. Efficacy and Safety of Long-Term Corticosteroid Monotherapy in 26 Cases of Nephrotic Syndrome with Biopsy-Proven Membranous Nephropathy Induced by Seronegative Hepatitis B Virus-Associated Glomerulonephritis. Zhang Y, Chen S, Yang D, Liu J, Zhang X, Yang X, Han H, Yang D. Nephron; 2021 May 31; 145(2):113-122. PubMed ID: 33561853 [Abstract] [Full Text] [Related]
13. Cryoglobulinemic glomerulonephritis in chronic hepatitis B infection. Enríquez R, Sirvent AE, Andrada E, Escolano C, Rodríguez JC, Millán I, Gutiérrez F, Amorós F. Ren Fail; 2010 May 31; 32(4):518-22. PubMed ID: 20446795 [Abstract] [Full Text] [Related]
14. Successful Use of Entecavir in Hepatitis B-associated Membranous Nephropathy. Mahajan V, D'Cruz S, Nada R, Sachdev A. J Trop Pediatr; 2018 Jun 01; 64(3):249-252. PubMed ID: 28977667 [Abstract] [Full Text] [Related]
15. Long-term lamivudine therapy in hepatitis B-associated membranous nephropathy? Ng YY, Yang WC, Lee ST. Kidney Int; 2006 Feb 01; 69(4):776. PubMed ID: 16518335 [No Abstract] [Full Text] [Related]
16. Adefovir and lamivudine in combination compared with adefovir monotherapy in HBeAg-negative adults with chronic hepatitis B virus infection and clinical or virologic resistance to lamivudine: a retrospective, multicenter, nonrandomized, open-label study. Pellicelli AM, Barbaro G, Francavilla R, Romano M, Barbarini G, Mazzoni E, Mecenate F, Paffetti A, Barlattani A, Struglia C, Villani R, Nauri L, Nosotti L, Armignacco O, Ferri F, Camporiondo MP, Soccorsi F, Club Epatologi Ospedalieri (CLEO) Group. Clin Ther; 2008 Feb 01; 30(2):317-23. PubMed ID: 18343270 [Abstract] [Full Text] [Related]
17. Lamivudine in hepatitis B-associated membranous nephropathy. Tang S, Lai FM, Lui YH, Tang CS, Kung NN, Ho YW, Chan KW, Leung JC, Lai KN. Kidney Int; 2005 Oct 01; 68(4):1750-8. PubMed ID: 16164651 [Abstract] [Full Text] [Related]
18. Hepatitis-B virus associated nephropathies: a clinicopathological study in 14 children. Ozdamar SO, Gucer S, Tinaztepe K. Pediatr Nephrol; 2003 Jan 01; 18(1):23-8. PubMed ID: 12488986 [Abstract] [Full Text] [Related]
19. Another case of HBV associated membranous glomerulonephritis resolving on lamivudine. Filler G, Feber J, Weiler G, Le Saux N. Arch Dis Child; 2003 May 01; 88(5):460. PubMed ID: 12716731 [No Abstract] [Full Text] [Related]
20. Long-term lamivudine monotherapy in renal-transplant recipients with hepatitis-B-related cirrhosis. Viganò M, Colombo M, Aroldi A, Lunghi G, Manenti E, Ponticelli C, Lampertico P. Antivir Ther; 2005 May 01; 10(6):709-13. PubMed ID: 16218169 [Abstract] [Full Text] [Related] Page: [Next] [New Search]